Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

BOBBI BROWN PRIMER PLUS RADIANCE SPF 35 - Health Canada Drug Approval Details

Approvals/Health Canada/BOBBI BROWN PRIMER PLUS RADIANCE SPF 35

Authorized

STANDARD

BOBBI BROWN PRIMER PLUS RADIANCE SPF 35

dist. bobbi brown professional cosmetics🇨🇦 Health Canada

Approval Date: Jul 4, 2025
Approval ID: d3372c62c28121bc
Company: dist. bobbi brown professional cosmetics
Type: Standard

Approval Details

Approval Id: d3372c62c28121bc
Drug Approval Canada Name: BOBBI BROWN PRIMER PLUS RADIANCE SPF 35
Product Name: BOBBI BROWN PRIMER PLUS RADIANCE SPF 35
Status: Cancelled Post Market
Status Date: 2021-09-21
Original Market Date: 2018-03-19
Din: 02466503
Drug Class: Human
Dosage Form: Cream
Route Of Administration: Topical
Schedule: OTC
Ahfs: 84:80.00
Atc Original: D02BA30 COMBINATIONS OF PROTECTIVES AGAINST UV-RADIATION
Atc Name: d 02 ba 30
Aig Number: 0527930010
Company Name: dist. bobbi brown professional cosmetics
Company Address: 550 Petrolia Road, Toronto, Ontario, Canada, M3J 2W3

Active Ingredients

OCTINOXATE

7.5 % / W/W

OCTISALATE

4 % / W/W

OXYBENZONE

2.5 % / W/W

ZINC OXIDE

3.3 % / W/W

TITANIUM DIOXIDE

1.1 % / W/W

Authorized

Quick Info

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

d3372c62c28121bc

Type

Standard

Back to Health Canada Approvals